United States Neuroendovascular Non-coils Market was valued at USD 0.5 Billion in 2022 and is projected to reach USD 1.0 Billion by 2030, growing at a CAGR of 8.8% from 2024 to 2030.
The U.S. neuroendovascular non-coils market is experiencing significant growth, driven by advancements in medical technology and an increasing prevalence of neurovascular disorders. As someone who has closely observed the evolution of neurointerventional procedures, it's fascinating to witness how non-coil devices are transforming patient outcomes.
According to recent data, the U.S. neurovascular devices market was valued at approximately $693.92 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 4.90% from 2024 to 2030. This growth trajectory underscores the expanding adoption of non-coil devices in clinical settings.
Several factors contribute to this upward trend:
Technological Innovations: The development of advanced devices, such as flow diverter devices and neurovascular stents, has enhanced the efficacy and safety of neuroendovascular procedures.
Minimally Invasive Procedures: There's a growing preference for minimally invasive techniques among both patients and healthcare providers, leading to shorter recovery times and reduced hospital stays.
Increasing Prevalence of Neurovascular Disorders: Conditions like aneurysms and strokes are becoming more common, necessitating effective treatment options.
In my experience, the integration of these devices into treatment protocols has revolutionized the management of complex neurovascular conditions. For instance, flow diverter devices have provided alternative solutions for aneurysms that were previously deemed untreatable with traditional coiling methods.
However, challenges persist. The high cost of these advanced devices can be a barrier to widespread adoption. Additionally, the need for specialized training to effectively use these technologies cannot be overlooked. Postmarket surveillance remains crucial to monitor device performance and ensure patient safety.
Looking ahead, the U.S. neuroendovascular non-coils market is poised for continued growth. Ongoing research and development, coupled with collaborative efforts between medical professionals and device manufacturers, are essential to address existing challenges and further enhance patient outcomes. As we navigate this evolving landscape, it's imperative to stay informed about the latest advancements and their practical applications in clinical practice.
Get an In-Depth Research Analysis of the US Neuroendovascular Non-coils Market Size And Forecast [2025-2032]
DeBuy Synthes
Medtronic
MicroVention
Stryker
Abiomed
AdvanSource Biomaterials
AGA Medical
Allium Medical
AngioDynamics
Angioslide
Atrium Medical
Biophan Technologies
Biosense Webster
Cardiac Science
CardiacAssist
Dextera Surgical
Cardio-Flow
Claret Medical
Contego Medical
Cook Group
Cryolife
Innovative Cardiovascular Solutions
Keystone Heart
St. Jude Medical
Phenox
InspireMD
Acandis
Transverse Medical
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Neuroendovascular Non-coils Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Neuroendovascular Non-coils Market
Stents
Flow Diversion Devices
Balloon Angioplasty Devices
Embolization Plugs
Aneurysm Treatment
Arteriovenous Malformation (AVM) Management
Intracranial Stenosis Treatment
Other Neurovascular Conditions
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Metallic Materials
Polymer-based Materials
Combination of Materials
Direct Sales
Distributors
Online Platforms
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Neuroendovascular Non-coils Market Research Analysis
1. Introduction of the US Neuroendovascular Non-coils Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Neuroendovascular Non-coils Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Neuroendovascular Non-coils Market, By Type
6. US Neuroendovascular Non-coils Market, By Application
7. US Neuroendovascular Non-coils Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Neuroendovascular Non-coils Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/